Skip to main content
ERAS logo

Erasca, Inc.

ERASNASDAQHealthcareBiotechnology

$13.39Today:- (-)1Y +514.46%

As of Oct 16, 2026 close

Market cap
$4.63B
P/E (TTM)
-
Forward P/E
-
Dividend yield
-
52-week range
$2.11$24.28
Volume (live)
-
Avg. volume (3M)
5.27M

Erasca (ERAS) Cash Flow Statement

In fiscal 2025 (fiscal year ended Dec 31, 2025), Erasca used $95.45M of cash in operating activities and spent $128.00K on capital expenditures. That left free cash flow of −$95.58M.

Erasca Cash Flow Statement Analysis

Values in millions USD

Scroll to see more
Cash flow statement showing operating, investing, and financing activities for Erasca, Inc. (ERAS) - Annual data in millions USD
BreakdownFY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019
Period endingDec 2025Dec 2024Dec 2023Dec 2022Dec 2021Dec 2020Dec 2019
Operating Activities
Net Income-124.55-161.65-125.04-242.81-122.76-101.66-12.04
Depreciation & Amortization3.113.813.732.640.830.540.31
Deferred Income Tax0.000.000.000.00-1.510.000.00
Stock Based Compensation24.9026.9726.2320.118.330.800.12
Change in Working Capital-3.331.740.8115.797.713.291.71
Change in Accounts Payable0.51-1.53-0.890.681.34-0.381.17
Change in Other Working Capital-3.843.271.70102.0027.813.670.54
Other Operating Activities4.4119.72-6.95102.0027.81-7.36-0.48
Net Cash from Operating Activities-95.46-109.42-101.22-103.26-79.60-32.69-10.38
Investing Activities
Capital Expenditures-0.13-22.56-21.78-16.55-18.89-0.95-0.60
Acquisitions0.000.000.004.007.680.000.00
Purchases of Investments-150.97-403.38-314.39-134.33-105.82-32.51-58.89
Sales/Maturities of Investments261.03269.33244.9579.8060.11-37.7538.60
Other Investing Activities-9.50-22.50-20.00-4.00-7.68-37.750.00
Net Cash from Investing Activities100.43-156.62-91.22-71.08-64.59-71.20-20.89
Financing Activities
Common Stock Issued1.10239.061.3095.25317.003.020.00
Other Financing Activities0.001.640.002.820.55139.9916.87
Net Cash from Financing Activities1.10240.701.3098.08439.40139.9916.87
Summary
Net Change in Cash6.07-25.34-191.14-76.27295.2136.11-14.40
Cash at Beginning of Period68.1593.48284.63360.9065.6929.5843.98
Cash at End of Period74.2168.1593.48284.63360.9065.6929.58
Free Cash Flow-95.58-131.98-122.99-119.82-98.49-33.63-10.98

Source: Company financial statements from annual and quarterly filings. Data as of Jun 30, 2026. Data sources and methodology

Frequently Asked Questions About Erasca Cash Flow

What is Erasca's free cash flow?

Erasca had negative free cash flow of $95.58M in fiscal 2025 (fiscal year ended Dec 31, 2025), operating cash flow of −$95.45M minus $128.00K of capital expenditures.

How much does Erasca spend on capital expenditures?

Erasca spent $128.00K on capital expenditures in fiscal 2025, compared with $22.56M a year earlier.

Does Erasca pay dividends or buy back shares?

Erasca's cash flow statement for fiscal 2025 shows no dividend payments or share repurchases.

What is free cash flow?

Free cash flow is operating cash flow minus capital expenditures. It is the cash a company has left for dividends, buybacks, debt repayment or acquisitions after funding its operations and investment. Full definition